Effect Of Latihan Pasrah Diri (Lpd) Plus Fluoxetin Compared With Fluoxetin Alone To Improve Fructosamine Level In Tipe 2 Diabetes Mellitus Patients With Depression Symptoms
Natsir Muin(1*), Agus Siswanto(2), Ahmad Husain Asdie(3)
(1) 
(2) 
(3) 
(*) Corresponding Author
Abstract
ABSTRACT
Background. Depression is a risk factor for diabetes and diabetes increase the risk for depression. Depression contributes to progression of diabetes mellitus. Examination of fructosamine is used to monitor blood sugar control for 2-3 weeks (according to age albumin). LPD evoke the relaxation response, which expected to improve symptoms of stress or depression.
Objective. To determine the decrease in fructosamine levels in the group of patients with diabetes mellitus with depression symptoms after administration of fluoxetine alone compared with a combination of fluoxetine and LPD.
Methods. This research conducted in Dr.Soeradji Tirtonegoro General Hospital, in May to August 2014. Distribution of data tested using the Shapiro-Wilk test. The differences between fructosamine and BDI (Beck Depression Inventory) before and after treatment tested with a pair t-test if normally distributed or Wilcoxon test if it was not normally distributed. The decrease in fructosamine and BDI both groups compared by independent t-test if normally distributed or Mann Whitney U test if not normally distributed. Differences were considered significant if p <0.05 with a confidence interval of 95%.
Result. There was a significant decrease in fructosamine levels in treatment group from 293.90±140.042 to 239.01±133.13 after treatment with p value 0.017 (p <0.05). Control group from 263.13±163.65 to 219.01±149.33 with p value 0.001 (p<0.05). The decrease of fructosamine levels not differ in the treatment group 67.24±102.71 than the control group 71.14 ± 72.77 with p value = 0.902 (p> 0.05).
Conclusion. LPD had no effect on fructosamine levels of type 2 diabetes mellitus patients with depression symptoms.
Keywords: LPD, symptoms of depression, fructosamine, BDI (Beck Depression Inventory)
Keywords
Full Text:
PDFReferences
References
American Diabetes Association. 2013. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. Vol 36 Supplement 1, S67.
Asdie A.H. 2000. Pathogenesis dan Terapi Diabetes Melitus Tipe 2.
Medika. Fakultas Kedokteran Universitas Gadjah Mada, Yogyakarta.
Khan H.A., Sobki S.H., Alhomida A.S., Khan S.A. 2007. Paired Values of Serum Fructosamine and Blood Glucose for the Screening of Gestational Diabetes Mellitus. Indian Jo of Clinical Biochemistry; 22 (1) 65-70.
Bogner H.R., Morales K.H., de Vries H.F., Cappola A.R. 2012. Integrated Management of Type 2 Diabetes Mellitus and Depression Treatment to Improve Medication Adherence: A Randomized Controlled Trial.Ann Fam Med;10:15-22.
Cuevas C.D. & Sanz E.J. 2006. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy. Curr Drug Safety:1;17-24.
McDowell I. dan Newell C. 1996. Measuring Health: A Guide to Rating Scales and Questionnaires 2nd ed. New York: Oxford University Press.
Anderson JR, Freedland KE, Clause RE, Lustman PJ. 2001. The Prevalence of Comorbid Depression in Adults with Diabetes. Diabetes Care. vol. 24 no. 6 1069-1078
Roy T., dan Lloyd C.E. 2012. Epidemiology of depression and diabetes: A systematic review. Journal of affective disorder. Supplement, Pages S8–S21
DOI: https://doi.org/10.22146/actainterna.48402
Article Metrics
Abstract views : 1199 | views : 860Refbacks
- There are currently no refbacks.
Copyright (c) 2019 Acta Interna: The Journal of Internal Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Acta Interna The Journal of Internal Medicine Indexed by:
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.